SIATA GIBSON: Open Payments
NPI 1023598091 · TEMPLE HILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 12 payments from 7 companies in 2025. Trend: 2023 $469 · 2024 $336 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $72 |
| Lilly USA, LLC | 2 | $38 |
| Amgen Inc. | 2 | $37 |
| Viatris Specialty LLC | 1 | $33 |
| Exact Sciences Corporation | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: REPATHA, YUPELRI, Cologuard Collection Kit, AIRSUPRA, ZEPBOUND, JARDIANCE, MOUNJARO.
Industry payments across MD — which companies pay providers there.
